277 related articles for article (PubMed ID: 9022830)
21. Inhibition of platelet thromboxane formation and phosphoinositides breakdown by diisoeugenol.
Lin CH; Kuo YH; Lin YL; Teng CM
J Pharm Pharmacol; 1994 Jan; 46(1):54-7. PubMed ID: 8201527
[TBL] [Abstract][Full Text] [Related]
22. Mechanism of inhibition of platelet aggregation by HCL-31D.
Chou TC; Li CY; Lee AR; Wu TM
Eur J Pharmacol; 2000 Jan; 387(2):125-31. PubMed ID: 10650152
[TBL] [Abstract][Full Text] [Related]
23. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
Yu SM; Wu TS; Teng CM
Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768
[TBL] [Abstract][Full Text] [Related]
24. Characterization of the antiplatelet effects of (2S)-5-methoxy-6-methylflavan-7-ol from Draconis Resina.
Tsai WJ; Hsieh HT; Chen CC; Kuo YC; Chen CF
Eur J Pharmacol; 1998 Apr; 346(1):103-10. PubMed ID: 9617759
[TBL] [Abstract][Full Text] [Related]
25. Mechanism of inhibition of platelet aggregation by rutaecarpine, an alkaloid isolated from Evodia rutaecarpa.
Sheu JR; Hung WC; Lee YM; Yen MH
Eur J Pharmacol; 1996 Dec; 318(2-3):469-75. PubMed ID: 9016940
[TBL] [Abstract][Full Text] [Related]
26. Antiplatelet effect of sanguinarine is correlated to calcium mobilization, thromboxane and cAMP production.
Jeng JH; Wu HL; Lin BR; Lan WH; Chang HH; Ho YS; Lee PH; Wang YJ; Wang JS; Chen YJ; Chang MC
Atherosclerosis; 2007 Apr; 191(2):250-8. PubMed ID: 16797553
[TBL] [Abstract][Full Text] [Related]
27. An antithrombotic agent, NQ301, inhibits thromboxane A2 receptor and synthase activity in rabbit platelets.
Jin YR; Cho MR; Lee KS; Lee JJ; Lim Y; Han XH; Oh KW; Hong JT; Yoo HS; Yun YP
Basic Clin Pharmacol Toxicol; 2005 Sep; 97(3):162-7. PubMed ID: 16128910
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of platelet aggregation by some flavonoids.
Tzeng SH; Ko WC; Ko FN; Teng CM
Thromb Res; 1991 Oct; 64(1):91-100. PubMed ID: 1776142
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of rabbit platelet aggregation by 1,4-naphthoquinones.
Ko FN; Sheu SJ; Liu YM; Huang TF; Teng CM
Thromb Res; 1990 Feb; 57(3):453-63. PubMed ID: 2156351
[TBL] [Abstract][Full Text] [Related]
30. The protective effects of paclitaxel on platelet aggregation through the inhibition of thromboxane A2 synthase.
Lee JJ; Yu JY; Lee JH; Zhang WY; Kim TJ; Myung CS; Yun YP
Arch Pharm Res; 2010 Mar; 33(3):387-94. PubMed ID: 20361303
[TBL] [Abstract][Full Text] [Related]
31. Effects of DK-002, a synthesized (6aS,cis)-9,10-Dimethoxy-7,11b-dihydro-indeno[2,1-c]chromene-3,6a-diol, on platelet activity.
Lee KS; Khil LY; Chae SH; Kim D; Lee BH; Hwang GS; Moon CH; Chang TS; Moon CK
Life Sci; 2006 Feb; 78(10):1091-7. PubMed ID: 16153663
[TBL] [Abstract][Full Text] [Related]
32. Antiplatelet effects of some aporphine and phenanthrene alkaloids in rabbits and man.
Teng CM; Hsueh CM; Chang YL; Ko FN; Lee SS; Liu KC
J Pharm Pharmacol; 1997 Jul; 49(7):706-11. PubMed ID: 9255715
[TBL] [Abstract][Full Text] [Related]
33. Benzodiazepines inhibit human platelet activation: comparison of the mechanism of antiplatelet actions of flurazepam and diazepam.
Romstedt K; Huzoor-Akbar
Thromb Res; 1985 May; 38(4):361-74. PubMed ID: 2990062
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of platelet thromboxane formation and phosphoinositides breakdown by osthole from Angelica pubescens.
Ko FN; Wu TS; Liou MJ; Huang TF; Teng CM
Thromb Haemost; 1989 Nov; 62(3):996-9. PubMed ID: 2556815
[TBL] [Abstract][Full Text] [Related]
35. Antiplatelet effects of clausine-D isolated from Clausena excavata.
Wu CC; Ko FN; Wu TS; Teng CM
Biochim Biophys Acta; 1994 Sep; 1201(1):1-6. PubMed ID: 7918571
[TBL] [Abstract][Full Text] [Related]
36. The inhibitory effect of 2-thienyl 2'-hydroxyphenyl ketone (C85) on platelet thromboxane formation.
Chou TC; Hsu LY; Yen MH; Ding YA
Thromb Res; 1996 Oct; 84(2):83-95. PubMed ID: 8897698
[TBL] [Abstract][Full Text] [Related]
37. Bakkenolide G, a natural PAF-receptor antagonist.
Liao CH; Ko FN; Wu TS; Teng CM
J Pharm Pharmacol; 1997 Dec; 49(12):1248-53. PubMed ID: 9466352
[TBL] [Abstract][Full Text] [Related]
38. PAF antagonism in vitro and in vivo by aglafoline from Aglaia elliptifolia Merr.
Ko FN; Wu TS; Liou MJ; Huang TF; Teng CM
Eur J Pharmacol; 1992 Jul; 218(1):129-35. PubMed ID: 1327822
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of thrombin- and collagen-induced phosphoinositides breakdown in rabbit platelets by a PAF antagonist--denudatin B, an isomer of kadsurenone.
Teng CM; Yu SM; Chen CC; Huang YL; Huang TF
Thromb Res; 1990 Jul; 59(1):121-30. PubMed ID: 2169076
[TBL] [Abstract][Full Text] [Related]
40. Mechanisms of antiplatelet activity of PC-09, a newly synthesized pyridazinone derivative.
Cherng SC; Huang WH; Shiau CY; Lee AR; Chou TC
Eur J Pharmacol; 2006 Feb; 532(1-2):32-7. PubMed ID: 16457809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]